Leverage your drug delivery with two webinars presented by DDP 2010

We're excited to deliver to you the most up to date information on drug delivery development . That's why we would like to extend this invitation to join us for the following COMPLIMENTARY upcoming webinars.

Glide SDI® – Injecting drugs and vaccines in a solid dosage form

Date: Wednesday, December 2, 2009
Time: 12:00 PM - 1:00 PM EST

Reserve your Webinar seat now at:
https://www1.gotomeeting.com/register/707185768
Mention priority code P1578W1TwitterBlog

Featured Speaker:
Charles Potter, CEO
Glide Pharma

About the Webinar:
Glide Pharma has developed the Glide SDI (Solid Dose Injector) for injecting drugs and vaccines in a solid dosage form, without the need for a needle. The technology offers many benefits, such as drug stability and controlled release, and is suitable for self-injection of drugs in a home environment. The Glide SDI is patent protected and in clinical trials has been preferred to an injection with a standard needle and syringe.

The seminar will give an overview of the Glide SDI, its benefits and pipeline of product opportunities. Data will be presented demonstrating the utility of the technology together with plans for the commercialization of the Glide SDI. In addition, an overview of the competitive landscape for injection technologies will be provided.

What you will learn:
• An introduction to the Glide Solid Dose Injector
• The benefits of injecting drugs in a solid dosage form
• The market opportunities for a differentiated drug delivery technology
• The competitive landscape for injection technologies

Leveraging Health: Driving Dividends through Value-Based Designs

Date: Thursday, December 3, 2009
Time: 2:00 PM - 3:00 PM EST

Reserve your Webinar seat now at:
https://www1.gotomeeting.com/register/215966568
Mention priority code P1578W2BlogTwitter

Featured Speaker:
Cyndy Nayer
Co-Founder and CEO
Center for Health Value Innovation

About the web seminar:
No matter how the reform legislation comes to pass, the ultimate outcomes must focus on health, productivity and economic improvement for the communities we serve. The Center for Health Value Innovation, through a grant from Takeda Pharmaceuticals, has prepared an overview of the levers of value-based design and a coordinated decision matrix for companies to consider as they revise their health plans for 2010 and beyond.

Through a suite of levers focused on prevention and wellness, chronic care management and care delivery, plan sponsors of all sizes, self-insured and fully-insured, can identify plan designs, incentives and disincentives that will shift populations to better health behaviors. How the plan sponsor chooses, and what questions are asked, is detailed in a forthcoming report. This webinar will frame the decisions and timelines for dividends in their companies and their communities.

What you will learn:
• What levers will drive better engagement of the consumer, the plan sponsor and the delivery system and result in improved outcomes?
• Where do we start? What if we are fully insured and cannot get integrated data—what do we do? What if we are a public entity, or working with unions, or operating under legislative barriers—is value based design still possible?
• What are reasonable expectations? What are the timelines for achievement and key messages for the C-Suite?
• How do we work with our vendors and health plans to promote, engage, and measure the outcomes?

Share this article with your social network, just click below to share now!

Share |